NASDAQ: UNCYUnicycive Therapeutics Inc Stock Ownership - Who owns Unicycive Therapeutics?
Insider buying vs selling
Have Unicycive Therapeutics Inc insiders been buying or selling?
No trades
There has been no insiders buying vs selling in the past 12 months.
Be the first to know when UNCY insiders and whales buy or sell their stock.
UNCY Shareholders
What type of owners hold Unicycive Therapeutics Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Gaurav Aggarwal | 94.26% | 11,370,152 | $77.32M | Insider |
| Vivo Capital LLC | 94.26% | 11,370,152 | $77.32M | Institution |
| Great Point Partners LLC | 91.02% | 10,980,000 | $74.66M | Institution |
| Octagon Capital Advisors LP | 82.90% | 10,000,000 | $68.00M | Institution |
| Nantahala Capital Management LLC | 77.86% | 9,391,994 | $63.87M | Institution |
| Logos Global Management LP | 42.10% | 5,078,927 | $34.54M | Institution |
| Walleye Capital LLC | 33.94% | 4,094,256 | $27.84M | Institution |
| Shalabh K. Gupta | 20.95% | 2,527,449 | $17.19M | Insider |
| Silverarc Capital Management LLC | 20.01% | 2,413,489 | $16.41M | Institution |
| Acuta Capital Partners LLC | 19.51% | 2,352,887 | $16.00M | Institution |
UNCY vs Biotech Stocks
Unicycive Therapeutics Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.